China to run large-scale 'Phase 3' clinical trial of its coronavirus vaccine in UAE

In a video conference between Abu Dhabi and Beijing, health authorities from United Arab Emirates anunced world’s first phase III trials of China’s inactivated Covid-19 vaccine. According to Sipharm's China National Biotec Group (CNBG), China has few confirmed COVID-19 cases and hence it does t meet conditions for phase III trial of vaccine's safety and efficacy on a large scale. And hence,  CNBG sought co-operation in UAE.  

“Inspired by UAE Leership’s vision and commitment to overcome pandemic through a global collaborative effort, a clinical cooperation agreement was signed between Chinese pharmaceutical giant Sipharm China National Biotec Group (CNBG) and Group 42 (G42), Abu Dhabi based leing artificial intelligence and cloud computing company,” Emirates news ncy said in a press release.  vaccine, developed by Wuhan Institute of Biological Products under CNBG affiliated to Sipharm, yielded positive results with respect to safety and efficacy in phase-1 and phase-2 clinical trials. G42 will le clinical trial operations for phase III in UAE under supervision of Department of Health of Abu Dhabi, according to release.  

Large delegation of representatives

meeting was presided over by Abdul Rahman Mohammed Al Owais, Minister of Health & Prevention, Sheikh Abdullah bin Mohammed Al Hamed, Chairman Department of Health Abu Dhabi, Ni Jian, Chinese ambassor to UAE, Dr Hamdan Musallam Al Mazrouei, Chairman of Board of Directors of Emirates Red Crescent and Dr Jamal Alkaabi, Acting Undersecretary of Department of Health.

From China, Liu Jingzhen, Chairman of Sipharm, Yang Xiaoming, Chairman of Sipharm CNBG, Li Can, President of Sipharm International, Hao Peng, Chairman of SASAC, Dr. Ali Al Dhaheri, UAE Ambassor to China, and a large delegation of representatives from Sipharm CNBG and Chinese medical authorities also took part in ceremony connecting via video conference from cities of Beijing and Wuhan. 

Re: Experts Voice Concerns Over US Government's Program For COVID-19 Vaccine

Re: AstraZeneca Aims To Boost Potential Supply Of COVID-19 Vaccine To 2 Billion

"w more than ever, nations need to work in close partnership between government and private sectors to create new initiatives, launch programs, develop policies, drive rigorous research, and develop capacity,” Abdul Rahman Mohammed Al Owais, Minister of Health & Prevention said. He ded, “United Arab Emirates welcomes all contributions by countries of world, invative entities and creative individuals who are committed to creating opportunities for joint collaboration towards confronting threat of COVID-19 and defeating this global pandemic." 

Sipharm CNBG inactivated vaccine alrey passed phases I and II clinical trials with 100% of volunteers generating antibodies after two doses in 28 days. With this joint collaboration, Group 42 and Sipharm CNBG aimed to develop development a safe and effective vaccine that is expected to enter market by  end of 2020 or early 2021.  

Re: China Will Make Any Vaccine 'global Public Goods'

Re: China Vows To Strengn International Cooperation In Search For Coronavirus Vaccine

(Ims Credit: Twitter/@ChineseEmbinUS)